INTRODUCTION Patients with rheumatoid arthritis (RA) and obesity (RAO) face unique challenges because obesity is linked to increased disease activity and poorer treatment outcomes.1 More than 30% of North American patients with RA are classified as having RAO.2 These individuals, in addition to individuals with obesity without RA, are in a chronic proinflammatory state due to the overproduction of inflammatory cytokines and adipocytokines.3 Heightened inflammation, along with worse arthritis...